• 1
    Gillies, S. D., Morrison, S. L., Oi, V. T. and Tonegawa, S., A tissue-specific transcriptional enhancer element is located in the major intron of a rearranged immunoglobulin heavy-chain gene. Cell 1983. 33: 717728.
  • 2
    Banerji, J., Olson, L. and Schaffner, W., A lymphoid-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy-chain genes. Cell 1983. 33: 729740.
  • 3
    Neuberger, M. S., Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. EMBO J. 1983. 2: 13731378.
  • 4
    Perlot, T. and Alt, F. W., Cis-regulatory elements and epigenetic changes control genomic rearrangements of the IgH locus. Adv. Immunol. 2008. 99: 132.
  • 5
    Dariavach, P., Williams, G. T., Campbell, K., Pettersson, S. and Neuberger, M. S., The mouse IgH 3′-enhancer. Eur. J. Immunol. 1991. 21: 14991504.
  • 6
    Chauveau, C. and Cogné, M., Palindromic structure of the IgH 3′ locus control region. Nat. Genet. 1996. 14: 1516.
  • 7
    Michaelson, J. S., Giannini, S. L. and Birshtein, B. K., Identification of 3′α-hs4, a novel Ig heavy chain enhancer element regulated at multiple stage of B cell differentiation. Nucleic Acids Res. 1995. 23: 975981.
  • 8
    Giannini, S. L., Singh, M., Calvo, C. F., Ding, G. and Birshtein, B. K., DNA regions flanking the mouse Ig 3′α enhancer are differentially methylated and DNAse I hypersensitive during B cell differentiation. J. Immunol. 1993. 150: 17721780.
  • 9
    Ong, J., Stevens, S., Roeder, R. G. and Eckhardt, L. A., 3′ IgH enhancer elements shift synergistic interactions during B cell development. J. Immunol. 1998. 160: 48964903.
  • 10
    Guglielmi, L., Le Bert, M., Truffinet, V., Cogné, M. and Denizot, Y., Insulators to improve expression of a 3′IgH LCR-driven reporter gene in transgenic mouse models. Biochem. Biophys. Res. Commun. 2003. 307: 466471.
  • 11
    Yan, Y., Park, S. S., Janz, S. and Eckhardt, L. A., In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3′ regulatory region induces myc expression at the immature stage of B cell development. Genes Chromosomes Cancer 2007. 46: 950959.
  • 12
    Cogné, M., Lansford, R., Bottaro, A., Zhang, J., Gorman, J., Young, F., Cheng, H. L. et al., A class switch control region at the 3′ end of the immunoglobulin heavy chain locus. Cell 1994. 77: 737747.
  • 13
    Manis, J. P., van der Stoep, N., Tian, M., Ferrini, R., Davidson, L., Bottaro, A. and Alt, F. W., Class switching in B cells lacking 3′ immunoglobulin. heavy chain enhancers. J. Exp. Med. 1998. 188: 14211431.
  • 14
    Bébin, A. G., Carrion, C., Marquet, M., Cogné, N., Lecardeur, S., Cogné, M. and Pinaud, E., In vivo redundant function of the 3′ IgH regulatory element HS3b in the mouse. J. Immunol. 2010. 184: 37103717.
  • 15
    Vincent-Fabert, C., Truffinet, V., Fiancette, R., Cogné, N., Cogné, M. and Denizot, Y., Ig synthesis and class switching do not require the presence of the hs4 enhancer in the 3′ IgH regulatory region. J. Immunol. 2009. 182: 69266932.
  • 16
    Pinaud, E., Khamlichi, A. A., Le Morvan, C., Drouet, M., Nalesso, V., Le Bert, M. and Cogné, M., Localization of the 3′ IgH locus elements that effect long-distance regulation of class switch recombination. Immunity 2001. 15: 187199.
  • 17
    Dunnick, W. A., Collins, J. T., Shi, J., Westfield, G., Fontaine, C., Hakimpour, P and Papavasiliou, F. N., Switch recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region. J. Exp. Med. 2009. 206: 26132623.
  • 18
    Vincent-Fabert, C., Fiancette, R., Pinaud, E., Truffinet, V., Cogné, N., Cogné, M. and Denizot, Y., Genomic deletion of the whole IgH 3′ regulatory region (hs3a, hs1,2, hs3b, hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood 2010. 116: 18951898.
  • 19
    Wuerffel, R., Wang, L., Grigera, F., Manis, J., Selsing, E., Perlot, T., Alt, F. W. et al., S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. Immunity 2007. 27: 711722.
  • 20
    Ju, Z., Volpi, S. A., Hassan, R., Martinez, N., Giannini, S. L., Gold, T. and Birshtein, B. K., Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3′ regulatory region. J. Biol. Chem. 2007. 282: 3516935178.
  • 21
    Jares, P., Colomer, D. and Campo, E., Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat. Rev Cancer 2007. 7: 750762.
  • 22
    Vitolo, U., Ferreri, A. J. M. and Montoto, S., Follicular lymphomas. Crit. Rev. Oncol. Hematol. 2008. 66: 248261.
  • 23
    Bergsagel, P. L. and Kuehl, W. M., Chromosome translocations in multiple myeloma. Oncogene 2001. 20: 56115622.
  • 24
    Blum, K. A., Lozanski, G. and Byrd, J. C., Adult Burkitt leukemia and lymphoma. Blood 2004. 104: 30093020.
  • 25
    Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D. et al., The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985. 318: 533538.
  • 26
    Truffinet, V., Pinaud, E., Cogné, N., Petit, B., Guglielmi, L., Cogné, M. and Denizot, Y., The 3′ IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J. Immunol. 2007. 179: 60336042.
  • 27
    Wang, J. and Boxer, L. M., Regulatory elements in the immunoglobulin heavy chain gene 3′-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. J. Biol. Chem. 2006. 280: 1276612773.
  • 28
    Vincent-Fabert, C., Fiancette, R., Truffinet, V., Cogné, N., Cogné, M. and Denizot, Y., Genetic background modulates susceptibility to oncogen-driven proliferation and lymphoma occurrence in mice carrying a deregulated c-myc transgene. Leuk. Res. 2009. 33: e203e206.
  • 29
    Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P. and Barbacid, M., Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat. Genet. 1999. 22: 4452.
  • 30
    Gostissa, M., Yan, C. T., Bianco, J. M., Cogné, M., Pinaud, E. and Alt, F. W., Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3′ regulatory region. Nature 2009. 462: 803808.
  • 31
    Bodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W. and Adams, J. M., Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 1994. 13: 21242130.
  • 32
    Lovec, H., Grzeschiczek, A., Kowalski, M. B. and Möröy, T., Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994. 13: 34873495.
  • 33
    Fiancette, R., Amin, R., Truffinet, V., Vincent-Fabert, C., Cogné, N., Cogné, M. and Denizot, Y., A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy chain locus 3′ enhancers does not promote by itself B-cell malignancies. Leuk. Res. 2010. 34: 10431051.
  • 34
    McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P. and Korsmeyer, S. J., Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989. 57: 7988.
  • 35
    Duan, H., Xiang, H., Ma, L. and Boxer, L. M., Fonctionnal long-range interactions of the IgH 3′ enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. Oncogene 2008. 27: 67206728.
  • 36
    Duan, H., Heckman, C. A. and Boxer, L. M., The immunoglobulin heavy-chain gene 3′ enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells. Oncogene 2007. 26: 26352641.